CA2403909A1 - Compositions et methodes de therapie et de diagnostic du cancer de la prostate - Google Patents
Compositions et methodes de therapie et de diagnostic du cancer de la prostate Download PDFInfo
- Publication number
- CA2403909A1 CA2403909A1 CA002403909A CA2403909A CA2403909A1 CA 2403909 A1 CA2403909 A1 CA 2403909A1 CA 002403909 A CA002403909 A CA 002403909A CA 2403909 A CA2403909 A CA 2403909A CA 2403909 A1 CA2403909 A1 CA 2403909A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- sequence
- cdna sequence
- polypeptide
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne des compositions et des méthodes de thérapie et de diagnostic du cancer, en particulier du cancer de la prostate. Des compositions servant d'illustration contiennent un ou plusieurs polypeptides spécifiques à la prostate, des portions immunogènes de ceux-ci, des polynucléotides codant ces polypeptides, une cellule de présentation d'antigène exprimant ces polypeptides, ainsi que des lymphocytes T spécifiques à des cellules exprimant ces polypeptides. Les compositions décrites sont utiles, par exemple, dans le diagnostic, la prévention et/ou le traitement de maladies, en particulier du cancer de la prostate.
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53685700A | 2000-03-27 | 2000-03-27 | |
US09/536,857 | 2000-03-27 | ||
US56810000A | 2000-05-09 | 2000-05-09 | |
US09/568,100 | 2000-05-09 | ||
US09/570,737 | 2000-05-12 | ||
US09/570,737 US7202342B1 (en) | 1999-11-12 | 2000-05-12 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/593,793 | 2000-06-13 | ||
US09/593,793 US7517952B1 (en) | 1997-02-25 | 2000-06-13 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US60578300A | 2000-06-27 | 2000-06-27 | |
US09/605,783 | 2000-06-27 | ||
US09/636,215 US6620922B1 (en) | 1997-02-25 | 2000-08-09 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/636,215 | 2000-08-10 | ||
US09/651,236 US6818751B1 (en) | 1997-08-01 | 2000-08-29 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/651,236 | 2000-08-29 | ||
US09/657,279 US6894146B1 (en) | 1997-02-25 | 2000-09-06 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/657,279 | 2000-09-06 | ||
US09/679,426 | 2000-10-02 | ||
US09/679,426 US6759515B1 (en) | 1997-02-25 | 2000-10-02 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/685,166 | 2000-10-10 | ||
US09/685,166 US6630305B1 (en) | 1999-11-12 | 2000-10-10 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US70972900A | 2000-11-09 | 2000-11-09 | |
US09/709,729 | 2000-11-09 | ||
PCT/US2001/009919 WO2001073032A2 (fr) | 2000-03-27 | 2001-03-27 | Compositions et methodes de therapie et de diagnostic du cancer de la prostate |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2403909A1 true CA2403909A1 (fr) | 2001-10-04 |
Family
ID=27582800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002403909A Abandoned CA2403909A1 (fr) | 2000-03-27 | 2001-03-27 | Compositions et methodes de therapie et de diagnostic du cancer de la prostate |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1311673A2 (fr) |
JP (1) | JP2004504808A (fr) |
AU (1) | AU2001249549A1 (fr) |
CA (1) | CA2403909A1 (fr) |
WO (1) | WO2001073032A2 (fr) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185830A1 (en) | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
EP2060630B1 (fr) | 1997-04-10 | 2012-10-24 | Stichting Katholieke Universiteit University Medical Centre Nijmegen | PCA3, gènes de PCA3, et procédés d'utilisation |
US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6329503B1 (en) | 1998-06-01 | 2001-12-11 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
US20060073150A1 (en) | 2001-09-06 | 2006-04-06 | Mary Faris | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
WO2001023550A2 (fr) | 1999-09-29 | 2001-04-05 | Diagnocure Inc. | Variantes l'arnm du pca3 dans les tissus benins et malins de la prostate |
US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
US6790631B1 (en) | 1999-10-05 | 2004-09-14 | Agensys, Inc. | G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
US7208280B2 (en) | 1999-10-05 | 2007-04-24 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer |
WO2001025401A2 (fr) * | 1999-10-07 | 2001-04-12 | Corixa Corporation | Utilisation d'une sequence codante de mycobacterium tuberculosis pour favoriser une expression stable et de fort rendement de proteines heterologues |
SI1542732T1 (sl) | 2000-06-20 | 2010-01-29 | Corixa Corp Csc The United Sta | Fuzijski proteini Mycobacterium tuberculosis |
EP1415005B1 (fr) | 2000-12-07 | 2012-11-21 | Novartis Vaccines and Diagnostics, Inc. | Retrovirus endogenes regules positivement dans le cancer de la prostate |
CA2443123A1 (fr) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Acides nucleiques et proteines correspondantes utiles pour la detection et le traitement de divers cancers |
EP1515982A4 (fr) * | 2001-05-09 | 2005-10-26 | Corixa Corp | Methodes et compositions pour la therapie et le diagnostic du cancer de la prostate |
EP1539805A4 (fr) * | 2001-05-15 | 2005-11-16 | Agensys Inc | Acides nucleiques et proteines correspondantes dits 101p3a11 ou phor-1 servant au traitement et a la detection de cancers |
US6897024B2 (en) | 2001-05-31 | 2005-05-24 | Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen | Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
US7700293B2 (en) | 2001-08-02 | 2010-04-20 | The Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7332290B2 (en) | 2001-08-02 | 2008-02-19 | The Regents Of The University Of Michigan | Dectection of AMACR cancer markers in urine |
US7229774B2 (en) | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
US7371841B2 (en) | 2002-01-25 | 2008-05-13 | Regents Of The University Of California | Methods of modulating cold sensory perception |
PT1511768E (pt) * | 2002-06-11 | 2007-07-16 | Glaxo Group Ltd | Composições imunogénicas |
WO2004016733A2 (fr) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Acides nucleiques et proteines correspondantes connues sous 251p5g2 que l'on utilise dans le traitement et la detection de cancers |
ES2427853T3 (es) | 2003-02-07 | 2013-11-04 | Diagnocure Inc. | Procedimiento para detectar cáncer de próstata en una muestra |
EP1742966B1 (fr) | 2004-04-22 | 2013-11-27 | Agensys, Inc. | Anticorps et molecules derivees de ceux-ci se liant aux proteines steap-1 |
CA2491067A1 (fr) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Rapport entre arnm dans les sediments urinaires ou l'urine en tant que marqueur pronostique du cancer de la prostate |
AU2006258655A1 (en) * | 2005-06-14 | 2006-12-21 | Dnavec Corporation | Method for production of antibody |
BRPI0616211A2 (pt) | 2005-09-19 | 2011-06-14 | Veridex Llc | mÉtodos para o diagnàstico de cÂncer pancreÁtico |
US7622573B2 (en) * | 2006-01-17 | 2009-11-24 | Biolex, Inc. | Expression control elements from the lemnaceae family |
WO2007100568A2 (fr) * | 2006-02-24 | 2007-09-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Récepteurs de lymphocytes t, matériaux associés et procédés d'utilisation |
US7820174B2 (en) | 2006-02-24 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | T cell receptors and related materials and methods of use |
SI2502938T1 (sl) | 2006-10-27 | 2015-05-29 | Genentech, Inc. | Protitelesa in imunokonjugati in njihove uporabe |
GB201513921D0 (en) * | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
RU2019134462A (ru) | 2017-04-03 | 2021-05-05 | Ф. Хоффманн-Ля Рош Аг | Антитела, связывающиеся с steap-1 |
WO2024052922A1 (fr) * | 2022-09-11 | 2024-03-14 | Yeda Research And Development Co. Ltd. | Anticorps anti-klk4 et leurs utilisations |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0976699A4 (fr) * | 1997-02-19 | 2009-06-03 | Chisso Asahi Fertilizer | Fertilisant granulaire enrobe d'une pellicule de protection decomposable et son procede de production |
EP1630235A3 (fr) * | 1997-02-25 | 2009-05-27 | Corixa Corporation | Composés pour l'immunodiagnostic du cancer de la prostate et méthodes pour leurs utilisations |
WO2000004149A2 (fr) * | 1998-07-14 | 2000-01-27 | Corixa Corporation | Compositions et methodes de therapie et de diagnostic du cancer de la prostate |
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
WO2001025272A2 (fr) * | 1999-10-04 | 2001-04-12 | Corixa Corporation | Compositions et methodes de therapie et de diagnostic du cancer de la prostate |
WO2001034802A2 (fr) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions et methodes de traitement et de diagnostic du cancer de la prostate |
HUP0203968A3 (en) * | 2000-01-14 | 2004-09-28 | Corixa Corp Seattle | Compositions and methods for the therapy and diagnosis of prostate cancer |
EP1515982A4 (fr) * | 2001-05-09 | 2005-10-26 | Corixa Corp | Methodes et compositions pour la therapie et le diagnostic du cancer de la prostate |
-
2001
- 2001-03-27 CA CA002403909A patent/CA2403909A1/fr not_active Abandoned
- 2001-03-27 WO PCT/US2001/009919 patent/WO2001073032A2/fr active Search and Examination
- 2001-03-27 JP JP2001570749A patent/JP2004504808A/ja active Pending
- 2001-03-27 AU AU2001249549A patent/AU2001249549A1/en not_active Abandoned
- 2001-03-27 EP EP01922786A patent/EP1311673A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2001073032A2 (fr) | 2001-10-04 |
EP1311673A2 (fr) | 2003-05-21 |
JP2004504808A (ja) | 2004-02-19 |
AU2001249549A1 (en) | 2001-10-08 |
WO2001073032A3 (fr) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6800746B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7939646B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7033827B2 (en) | Prostate-specific polynucleotide compositions | |
CA2403909A1 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
EP1988097A1 (fr) | Compositions et procédés pour le traitement et le diagnostic du cancer de la prostate | |
CA2397741A1 (fr) | Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate | |
US6943236B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7074898B2 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
JP2004537252A (ja) | 前立腺癌の治療及び診断のための組成物及び方法 | |
US20020192763A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6620922B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6630305B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6759515B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6818751B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020193296A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020081680A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20060269532A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7048931B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6894146B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020051977A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7517952B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
JP2008271978A (ja) | 前立腺癌の治療及び診断のための組成物及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |